arrow
M

Manuel Rodrigues

psl research university
H指数:33
被引数:8,462

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial

在GNAQ/GNA11突变型黑色素瘤中具有Gq/11抑制剂载荷的抗PMEL抗体−药物偶联物:一项1期临床试验

2026-07-130
OA
A 2025 inventory in oncology news

2025年肿瘤学新闻盘点

2026-01-010
OAAI
The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201

阿伐木单抗与德法他尼联用治疗复发性低级别浆液性卵巢癌:ENGOT-OV60/GOG-3052/RAMP 201 II期临床试验的通俗语言总结

2025-12-120
OAAI
Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial.

转移性子宫内膜癌患者中分子分型与总生存期的关联:UTOLA II期GINECO试验的辅助结果。

2025-11-210
PRE
Genetic background predicts uveal melanoma patients’ outcomes

遗传背景预测葡萄膜黑色素瘤患者的预后

2025-10-100
OAAI
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial

奥拉帕利维持治疗在铂类为基础化疗后的晚期/转移性子宫内膜癌中的应用:GINECO随机IIb期UTOLA试验

2025-08-260
OAAI
Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian Database

无铂间期(PFI)及维持治疗在复发性卵巢癌中的作用:解释生存率的法国真实世界ESME卵巢数据库分析

2025-08-070
PRE
Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert Centres

来自四个EURACAN专家中心关于tebentafusp在转移性眼葡萄膜黑色素瘤患者中的真实世界数据

2025-07-100
OA
PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network

PARP抑制剂在铂敏感复发性卵巢癌中的维持治疗:来自Unicancer网络的现实世界经验

2025-05-110
OA
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial

奥拉帕利联合间质环磷酰胺和二甲双胍治疗复发性晚期/转移性子宫内膜癌的女性:ENDOLA I/II期试验

2025-02-200
OA
A Retrospective Multicentre Study To Evaluate The Impact Of Platinum-Free Interval On Progression-Free And Overall Survival In Patients With Recurrent Epithelial Ovarian Cancer, Using Real-World Data From The ESME Database

一项回顾性多中心研究,旨在评估无铂间隔对复发性上皮性卵巢癌患者无进展生存期和总生存期的影响,使用来自ESME数据库的真实世界数据。

2025-02-010
PRE
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
2024-10-140
OAAI
Validation of circulating tumor DNA for prognostication and monitoring in metastatic endometrial carcinoma: Ancillary results from the phase II randomized GINECO trial UTOLA

循环肿瘤DNA在转移性子宫内膜癌预后判断和监测中的验证:GINECO试验UTOLA II期随机研究的附加结果

2024-09-010
PRE